
Charities donate $5.5m to expand access to rare disease treatment
Cure Sanfilippo Foundation and the National MPS Society have agreed a combined $5.5 million strategic investment in Spruce Biosciences, which will go towards the Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) for Sanfilippo Syndrome Type B (or MPS IIIB) Expanded Access Program (EAP). Samir Gharib, President and Chief… Read More
